This course is perfectly suited for graduates in related science areas who are interested in/are pursuing careers in the pharmaceutical industry, regulatory agencies and research laboratories. It is also appealing to intending PhD researchers. Students are exposed to current and emerging trends in drug discovery, drug design and regulatory sciences through a combination of lectures, seminars, practicals delivered by highly experienced academics and industrial experts. Future-proof course design ensures graduates would continually meet the core needs of the global pharmaceutical industry. Superb modern facilities and placements to the pharmaceutical industry exposes students to hands-on and real-life experiences.
Students must hold one of the following:
Those applicants seeking entry with appropriate experiences will be required to demonstrate the suitability of this experience both on application and at interview.
International students should have an English language qualification, IELTS at 6.5 (no individual mark lower than 6.0), TOEFL at 600 (paper) and 250 (CBE) with a TWE of 4.
Admission with Advanced Standing: students may be able to claim exemption from individual modules where they can demonstrate an appropriate level of prior qualification or experience. This will not normally be more than two modules. Applications for accreditation of prior learning, whether experiential or certified, will be considered on an individual basis and applicants should initially make arrangements to discuss their case with the Course Leader at the time of application.
Find out more about Postgraduate courses at our Postgraduate Advice Event on 23 June 2019
HIGHLIGHTS OF THE COURSE
Placements are to the pharmaceutical industry are carried out. The industry may be involved in the design/ drive of a research project. In such instances, the student may also visit the industry
Graduates would be equipped with a knowledge and skills base that allows pursuit of both scientific and non-scientific careers in a variety of pharmaceutical work environments. This may include jobs in the pharmaceutical industry, regulatory agencies, academia, further studies-PhD etc.
Progression routes include further research towards higher degrees and other doctorate courses
ALTERNATIVE RESEARCH OPPORTUNITIES
The MSc (by Research) is very similar to a PhD, but with a research project designed to take 12 months. It is not intended as a first step towards a PhD, but rather as an alternative to a PhD. There are no associated lectures, classes or written examinations. Find out more at our Faculty research website : https://www.uclancbsresearch.co.uk/msc-by-research/
You can apply for many of the postgraduate UCLan courses using our Online Application System.
Students go on placement to some of these and industrial experts from some of these partners come in to deliver guest lectures and seminars. This also ensures students have knowledge of current/emerging practices and trends in the pharmaceutical industry.
Students will be assessed through a variety of means including; presentations, examinations, posters (with oral questioning during the poster session), case studies, data interpretation exercises, essays and scientific reports, practical report, project report and oral examination
The learning environment includes placement visits to the pharmaceutical industry and visits from the industry where expertise is shared with practitioners. Excellent staff, who are research-active with diverse academic, industrial and clinical expertise.
Current academic expertise include; Ann Urmston (Pharmacy practice), Elaine Crombie (Medicinal chemistry and calculations), Dr. Abdullah Isreb (Crystallography & Nanoformulation), Dr. Amina Ferraz (Respiratory drug delivery), Dr. Christopher Smith (Pharmacology), Dr. Clare Lawrence (Cell & molecular biology), Dr. Enoche Oga (Biopharmaceutics, absorption enhancement and modelling), Dr. Leroy Shervington (Drug Design and Pharmaceutical Analysis), Dr. Marta Krysmann (Pharmaceutical Chemistry), Dr. Mohamed Albed Alhnan (3D Printing, & personalised medicine), Dr. Mohamed Elsawy (Hydrogels & nanomedicine), Dr. Sarah Wilson (Health ethics), Dr. Tim Snape (Pharmaceutical Chemistry), Dr. Zhengyuan Zhou (advanced drug delivery systems), Prof Kamalinder Singh (Drug delivery and Nanomedicine), Prof Rob Forbes (Biopharmaceutics & nanotechnology)